Search hospitals > Missouri > Chesterfield
The Lung Research Center, LLC
Claim this profileChesterfield, Missouri 63017
Global Leader in Idiopathic Pulmonary Fibrosis
Conducts research for Interstitial Lung Disease
Conducts research for Fibrosing Alveolitis
Conducts research for Chronic Bronchitis
Conducts research for Chronic Cough
29 reported clinical trials
1 medical researcher
Summary
The Lung Research Center, LLC is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Fibrosing Alveolitis, Chronic Bronchitis, Chronic Cough and other specialties. The Lung Research Center, LLC is involved with conducting 29 clinical trials across 20 conditions. There are 1 research doctors associated with this hospital, such as Neil A Ettinger.Top PIs
Clinical Trials running at The Lung Research Center, LLC
Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Chronic Obstructive Pulmonary Disease
Bronchiectasis
Connective Tissue Disorder
Sarcoidosis
Systemic Sclerosis
Rheumatoid Arthritis
Fibrosing Alveolitis
Fibrosing Colonopathy
BI 1015550
for Pulmonary Fibrosis
This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. The goal of this study is to find out how well people with pulmonary fibrosis tolerate long- term treatment with nerandomilast. The study also tests whether nerandomilast improves lung function and prolongs the time until symptoms get worse, participants need to go to the hospital, or die. Every participant takes nerandomilast as tablets for up to 1 year and 10 months. The participants may also continue their regular treatment for pulmonary fibrosis during the study. Participants visit their doctors regularly. During these visits, the doctors collect information on any health problems of the participants. Participants also regularly do lung function tests.
Recruiting2 awards Phase 3
BMS-986278
for Pulmonary Fibrosis
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
Recruiting1 award Phase 37 criteria
Inhaled Treprostinil
for Pulmonary Fibrosis
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Recruiting1 award Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at The Lung Research Center, LLC?
The Lung Research Center, LLC is a medical facility located in Chesterfield, Missouri. This center is recognized for care of Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Fibrosing Alveolitis, Chronic Bronchitis, Chronic Cough and other specialties. The Lung Research Center, LLC is involved with conducting 29 clinical trials across 20 conditions. There are 1 research doctors associated with this hospital, such as Neil A Ettinger.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.